iBio, Inc. (IBIO)
NASDAQ: IBIO · Real-Time Price · USD
1.630
-0.080 (-4.68%)
At close: Apr 28, 2026, 4:00 PM EDT
1.658
+0.028 (1.70%)
After-hours: Apr 28, 2026, 7:23 PM EDT
iBio, Inc. Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for iBio, Inc. stock have an average target of 4.75, with a low estimate of 2.00 and a high estimate of 7.00. The average target predicts an increase of 191.41% from the current stock price of 1.63.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for iBio, Inc. stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 1 | 2 | 2 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 3 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Chardan Capital | Chardan Capital | Strong Buy Maintains $5 | Strong Buy | Maintains | $5 | +206.75% | Apr 9, 2026 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $5 | Strong Buy | Maintains | $5 | +206.75% | Mar 18, 2026 |
| Jones Trading | Jones Trading | Strong Buy Initiates $7 | Strong Buy | Initiates | $7 | +329.45% | Mar 3, 2026 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $5 | Strong Buy | Maintains | $5 | +206.75% | Feb 12, 2026 |
| Oppenheimer | Oppenheimer | Buy Initiates $5 | Buy | Initiates | $5 | +206.75% | Oct 21, 2025 |
Financial Forecast
Revenue This Year
183.60K
from 400.00K
Decreased by -54.10%
Revenue Next Year
122.40K
from 183.60K
Decreased by -33.33%
EPS This Year
-0.32
from -1.75
EPS Next Year
-0.30
from -0.32
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 525,000 | 525,000 | ||||||
| Avg | 183,600 | 122,400 | ||||||
| Low | 98,000 | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 31.3% | 185.9% | ||||||
| Avg | -54.1% | -33.3% | ||||||
| Low | -75.5% | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | -0.29 | -0.20 | ||
| Avg | -0.32 | -0.30 | ||
| Low | -0.34 | -0.38 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | - | - | ||
| Avg | - | - | ||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.